Predictive value of early maximal exercise test and thallium scintigraphy after successful percutaneous transluminal coronary angioplasty
- PMID: 3155619
- PMCID: PMC481739
- DOI: 10.1136/hrt.53.2.194
Predictive value of early maximal exercise test and thallium scintigraphy after successful percutaneous transluminal coronary angioplasty
Abstract
Restenosis of the dilated vessel after percutaneous transluminal coronary angioplasty can be detected by non-invasive procedures but their ability to predict later restenosis soon after a successful angioplasty as well as recurrence of angina has not been assessed. A maximal exercise test and myocardial thallium perfusion scintigraphy were, therefore, performed in 91 asymptomatic patients a median of 5 weeks after they had undergone a technically successful angioplasty. Primary success of the procedure was confirmed by the decrease in percentage diameter stenosis from 64(12)% to 30(13)% as measured from the coronary angiograms and in the trans-stenotic pressure gradient (normalised for mean aortic pressure) from 0.61(0.16) to 0.17(0.09). A clinical follow up examination (8.6(4.9) months later) was carried out in all patients and a late coronary angiogram obtained in 77. The thallium perfusion scintigram showing the presence or absence of a reversible defect was highly predictive for restenosis whereas the exercise test was not. The positive predictive value of an abnormal scintigram was 82% compared with 60% for the exercise test (ST segment depression/or angina or both at peak workload). Angina or a new myocardial infarction occurred in 60% of patients with abnormal and in 21% of patients with normal scintigrams.
Similar articles
-
Early detection of restenosis after successful percutaneous transluminal coronary angioplasty by exercise-redistribution thallium scintigraphy.Am J Cardiol. 1985 Feb 1;55(4):357-61. doi: 10.1016/0002-9149(85)90375-3. Am J Cardiol. 1985. PMID: 3155896
-
Quantitative exercise thallium-201 scintigraphy for predicting angina recurrence after percutaneous transluminal coronary angioplasty.Am J Cardiol. 1989 Mar 1;63(9):517-21. doi: 10.1016/0002-9149(89)90891-6. Am J Cardiol. 1989. PMID: 2521977
-
The clinical efficacy and scintigraphic evaluation of post-coronary bypass patients undergoing percutaneous transluminal coronary angioplasty for recurrent angina pectoris.Am Heart J. 1989 Jan;117(1):60-71. doi: 10.1016/0002-8703(89)90657-1. Am Heart J. 1989. PMID: 2521419
-
Role of exercise testing in relationship to coronary artery bypass surgery and percutaneous transluminal coronary angioplasty.Cardiology. 1986;73(4-5):242-58. doi: 10.1159/000174018. Cardiology. 1986. PMID: 2944582 Review.
-
Strategy of diagnostic imaging before and after PTCA.Echocardiography. 1995 May;12(3):303-9. doi: 10.1111/j.1540-8175.1995.tb00553.x. Echocardiography. 1995. PMID: 10150476 Review.
Cited by
-
A comparative study of restenosis rates in bare metal and drug-eluting stents.Int J Angiol. 2010 Summer;19(2):e66-72. doi: 10.1055/s-0031-1278368. Int J Angiol. 2010. PMID: 22477592 Free PMC article.
-
Assessment of percutaneous transluminal coronary angioplasty with 123IODO-heptadecanoic acid.Eur J Nucl Med. 1987;12(12):605-8. doi: 10.1007/BF00284535. Eur J Nucl Med. 1987. PMID: 2953602
-
Myocardial scintigraphy--25 years after start.Eur J Nucl Med. 1988;13(12):619-36. doi: 10.1007/BF00256390. Eur J Nucl Med. 1988. PMID: 3282885 Review.
-
Role of myocardial perfusion imaging after coronary revascularization in symptom-free patients: are low-risk patients really low?J Nucl Cardiol. 2002 Sep-Oct;9(5):550-3. doi: 10.1067/mnc.2002.124476. J Nucl Cardiol. 2002. PMID: 12360136 No abstract available.
-
Nuclear cardiology: the interventionalists' perspective.J Nucl Cardiol. 1994 Jul-Aug;1(4):415-9. doi: 10.1007/BF02939962. J Nucl Cardiol. 1994. PMID: 9420724 No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical